SCHEMBL2311037

SCHEMBL2311037

OCCc1cc2ccccc2c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM4 Q8TD43 1/20 0.48
DHODH Q02127 1/20 0.46
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 2/20 0.43
HIF1A Q16665 1/20 0.43
CYP1B1 Q16678 1/20 0.43
HPRT1 P00492 1/20 0.41
CYP1A2 P05177 2/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40
RAD52 P43351 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
CYP2A6 P11509 1/20 0.39
TSHR P16473 1/20 0.39
FAAH O00519 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2307245 0.88 ALDH1A1 (0.45) TRPM4DHODHALDH1A1HSD17B10HIF1A
SCHEMBL2311085 0.87 CHEK1 (0.40) TRPM4DHODHALDH1A1HSD17B10HIF1A
SCHEMBL2308691 0.86 CYP1A2 (0.42) TRPM4DHODHALDH1A1HSD17B10HIF1A
SCHEMBL2313600 0.86 CYP1A2 (0.42) TRPM4DHODHALDH1A1HSD17B10HIF1A
SCHEMBL2309984 0.85 ALDH1A1 (0.52) TRPM4ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL2310494 0.85 TDP1 (0.48) TRPM4DHODHALDH1A1HSD17B10POLB
SCHEMBL615452 0.85 TRPM4 (0.54) TRPM4DHODHALDH1A1HSD17B10HIF1A
SCHEMBL2310404 0.84 ALDH1A1 (0.56) TRPM4ALDH1A1HSD17B10HIF1ACYP1B1
SCHEMBL2310231 0.83 CYP1A2 (0.43) TRPM4DHODHALDH1A1HSD17B10HIF1A
SCHEMBL2313386 0.83 TDP1 (0.41) TRPM4DHODHALDH1A1HIF1AHPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970811-A2 VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND A POLYAROMATIC HYDROCARBON Chevron Oronite Company LLC (US) 2016-01-20 EP disclosed
WO-2014149086-A2 VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND A POLYAROMATIC HYDROCARBON CHEVRON ORONITE COMPANY LLC (US) 2014-09-25 WO disclosed
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed
US-20030108892-A1 Irradiation of pyrene and dimethyl aniline in water, forming labels for oligonucleotides, proteins, ceramics, transistors, semiconductors, insulators, or glass THE UNIVERSITY OF MANCHESTER (GB) 2003-06-12 US disclosed
EP-1242360-A2 EXCIPLEXES THE VICTORIA UNIVERSITY OF MANCHESTER (GB) 2002-09-25 EP disclosed
WO-2001046121-A2 EXCIPLEXES THE VICTORIA UNIVERSITY OF MANCHESTER (GB) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108892-A1 Irradiation of pyrene and dimethyl aniline in water, forming labels for oligonucleotides, proteins, ceramics, transistors, semiconductors, insulators, or glass MDM4, PHAX, DIMT1 TRPM4 676/4885DHODH 2155/4885ALDH1A1 4658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.